166 related articles for article (PubMed ID: 37024211)
1. Genetic Markers Predisposing to Nonalcoholic Steatohepatitis.
Sohal A; Chaudhry H; Kowdley KV
Clin Liver Dis; 2023 May; 27(2):333-352. PubMed ID: 37024211
[TBL] [Abstract][Full Text] [Related]
2. Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease.
Paternostro R; Staufer K; Traussnigg S; Stättermayer AF; Halilbasic E; Keritam O; Meyer EL; Stift J; Wrba F; Sipos B; Canbay A; Schlattjan M; Aigner E; Datz C; Stickel F; Schafmayer C; Hampe J; Buch S; Prager G; Munda P; Mandorfer M; Ferenci P; Trauner M
Hepatol Int; 2021 Aug; 15(4):922-933. PubMed ID: 34076851
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort
Anstee QM; Darlay R; Cockell S; Meroni M; Govaere O; Tiniakos D; Burt AD; Bedossa P; Palmer J; Liu YL; Aithal GP; Allison M; Yki-Järvinen H; Vacca M; Dufour JF; Invernizzi P; Prati D; Ekstedt M; Kechagias S; Francque S; Petta S; Bugianesi E; Clement K; Ratziu V; Schattenberg JM; Valenti L; Day CP; Cordell HJ; Daly AK;
J Hepatol; 2020 Sep; 73(3):505-515. PubMed ID: 32298765
[TBL] [Abstract][Full Text] [Related]
4. Genetic Risk Factors and Disease Modifiers of Nonalcoholic Steatohepatitis.
Kozlitina J
Gastroenterol Clin North Am; 2020 Mar; 49(1):25-44. PubMed ID: 32033763
[TBL] [Abstract][Full Text] [Related]
5. The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2.
Anstee QM; Day CP
Semin Liver Dis; 2015 Aug; 35(3):270-90. PubMed ID: 26378644
[TBL] [Abstract][Full Text] [Related]
6. Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers.
Kawaguchi T; Shima T; Mizuno M; Mitsumoto Y; Umemura A; Kanbara Y; Tanaka S; Sumida Y; Yasui K; Takahashi M; Matsuo K; Itoh Y; Tokushige K; Hashimoto E; Kiyosawa K; Kawaguchi M; Itoh H; Uto H; Komorizono Y; Shirabe K; Takami S; Takamura T; Kawanaka M; Yamada R; Matsuda F; Okanoue T
PLoS One; 2018; 13(1):e0185490. PubMed ID: 29385134
[TBL] [Abstract][Full Text] [Related]
7. Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis.
Carlsson B; Lindén D; Brolén G; Liljeblad M; Bjursell M; Romeo S; Loomba R
Aliment Pharmacol Ther; 2020 Jun; 51(12):1305-1320. PubMed ID: 32383295
[TBL] [Abstract][Full Text] [Related]
8. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML
Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529
[TBL] [Abstract][Full Text] [Related]
9. Advances in the genetics of nonalcoholic fatty liver disease.
Ajmera V; Loomba R
Curr Opin Gastroenterol; 2023 May; 39(3):150-155. PubMed ID: 37144531
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Scoring System, Based on Genetic and Clinical Factors, to Determine Risk of Steatohepatitis in Asian Patients with Nonalcoholic Fatty Liver Disease.
Koo BK; Joo SK; Kim D; Lee S; Bae JM; Park JH; Kim JH; Chang MS; Kim W
Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2592-2599.e10. PubMed ID: 32062042
[TBL] [Abstract][Full Text] [Related]
11. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
[TBL] [Abstract][Full Text] [Related]
12. The genetic backgrounds in nonalcoholic fatty liver disease.
Seko Y; Yamaguchi K; Itoh Y
Clin J Gastroenterol; 2018 Apr; 11(2):97-102. PubMed ID: 29492830
[TBL] [Abstract][Full Text] [Related]
13. Genetics of nonalcoholic fatty liver disease in Asian populations.
Kumar A; Shalimar ; Walia GK; Gupta V; Sachdeva MP
J Genet; 2019 Mar; 98():. PubMed ID: 30945694
[TBL] [Abstract][Full Text] [Related]
14. African genetic ancestry is associated with lower frequency of PNPLA3 G allele in non-alcoholic fatty liver in an admixed population.
Cavalcante LN; Porto J; Mazo D; Longatto-Filho A; Stefano JT; Lyra AC; Carrilho FJ; Reis RM; Alves VAF; Sanyal AJ; Oliveira CP
Ann Hepatol; 2022; 27(6):100728. PubMed ID: 35710086
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237
[TBL] [Abstract][Full Text] [Related]
16. Genetic predisposition in nonalcoholic fatty liver disease.
Sookoian S; Pirola CJ
Clin Mol Hepatol; 2017 Mar; 23(1):1-12. PubMed ID: 28268262
[TBL] [Abstract][Full Text] [Related]
17. Genetics and epigenetics of NAFLD and NASH: Clinical impact.
Eslam M; Valenti L; Romeo S
J Hepatol; 2018 Feb; 68(2):268-279. PubMed ID: 29122391
[TBL] [Abstract][Full Text] [Related]
18. Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in Japan.
Akuta N; Kawamura Y; Arase Y; Suzuki F; Sezaki H; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Suzuki Y; Ikeda K; Kumada H
Gut Liver; 2016 May; 10(3):437-45. PubMed ID: 26610348
[TBL] [Abstract][Full Text] [Related]
19. Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver Disease.
Taliento AE; Dallio M; Federico A; Prati D; Valenti L
Int J Environ Res Public Health; 2019 Aug; 16(15):. PubMed ID: 31375010
[TBL] [Abstract][Full Text] [Related]
20. Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients.
Tai CM; Huang CK; Tu HP; Hwang JC; Yeh ML; Huang CF; Huang JF; Dai CY; Chuang WL; Yu ML
Medicine (Baltimore); 2016 Mar; 95(12):e3120. PubMed ID: 27015186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
